Theriva Biologics, Inc. (TOVX)
0.24
0.00 (0.00%)
USD |
NYAM |
Aug 24, 16:00
0.24
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Total Assets (Quarterly) : 34.86M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.86M |
| March 31, 2026 | 38.25M |
| December 31, 2025 | 43.69M |
| September 30, 2025 | 30.84M |
| June 30, 2025 | 35.83M |
| March 31, 2025 | 32.16M |
| December 31, 2024 | 39.74M |
| September 30, 2024 | 40.11M |
| June 30, 2024 | 42.39M |
| March 31, 2024 | 48.73M |
| December 31, 2023 | 60.21M |
| September 30, 2023 | 61.54M |
| June 30, 2023 | 65.45M |
| March 31, 2023 | 67.89M |
| December 31, 2022 | 75.03M |
| September 30, 2022 | 78.70M |
| June 30, 2022 | 82.33M |
| March 31, 2022 | 89.00M |
| December 31, 2021 | 70.36M |
| September 30, 2021 | 75.12M |
| June 30, 2021 | 77.26M |
| March 31, 2021 | 79.05M |
| December 31, 2020 | 8.41M |
| September 30, 2020 | 7.203M |
| June 30, 2020 | 9.582M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.89M |
| December 31, 2019 | 17.24M |
| September 30, 2019 | 20.74M |
| June 30, 2019 | 24.00M |
| March 31, 2019 | 26.63M |
| December 31, 2018 | 30.14M |
| September 30, 2018 | 10.80M |
| June 30, 2018 | 8.418M |
| March 31, 2018 | 12.47M |
| December 31, 2017 | 18.84M |
| September 30, 2017 | 23.28M |
| June 30, 2017 | 15.74M |
| March 31, 2017 | 17.72M |
| December 31, 2016 | 22.50M |
| September 30, 2016 | 8.248M |
| June 30, 2016 | 16.33M |
| March 31, 2016 | 22.74M |
| December 31, 2015 | 30.84M |
| September 30, 2015 | 42.63M |
| June 30, 2015 | 11.84M |
| March 31, 2015 | 13.72M |
| December 31, 2014 | 19.14M |
| September 30, 2014 | 4.741M |
| June 30, 2014 | 9.289M |
| March 31, 2014 | 12.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 285.13M |
| Nkarta, Inc. | 337.64M |
| Unicycive Therapeutics, Inc. | 72.03M |
| OnKure Therapeutics, Inc. | 179.35M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 22.67M |
| Shareholders Equity (Quarterly) | 12.19M |
| Debt to Equity Ratio | 0.2915 |
| Current Ratio | 1.129 |
| Net Debt Paydown Yield | -1.22% |